Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
6.32
+0.01 (0.08%)
Feb 5, 2025, 3:24 PM EST - Market open
Myomo Revenue
Myomo had revenue of $9.21M in the quarter ending September 30, 2024, with 81.27% growth. This brings the company's revenue in the last twelve months to $25.24M, up 36.23% year-over-year. In the year 2023, Myomo had annual revenue of $19.24M with 23.70% growth.
Revenue (ttm)
$25.24M
Revenue Growth
+36.23%
P/S Ratio
7.56
Revenue / Employee
$238,105
Employees
106
Market Cap
209.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
Dec 31, 2019 | 3.84M | 1.39M | 57.02% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
MYO News
- 2 months ago - Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock - Business Wire
- 2 months ago - Myomo, Inc. Announces Proposed Public Offering of Common Stock - Business Wire
- 3 months ago - Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Myomo Reports Record Third Quarter Financial and Operating Results - Business Wire
- 3 months ago - CMS Decision And O&P Network Build Out Make Myomo A Buy - Seeking Alpha
- 3 months ago - Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage - Business Wire
- 3 months ago - Myomo to Report Third Quarter Financial Results on November 6, 2024 - Business Wire
- 4 months ago - Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit - Business Wire